VYGR VOYAGER THERAPEUTICS INC
2026Q1 · CUSIP 92915B106 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
134
Δ holders QoQ
+10
Breadth percentile
Top 29%
Whale holders
71
Δ whales
+3
Inst. holding value
$128M
New positions
28
Closed positions
18
Price momentum (1Q)
+3.5%
Put / Call
2/3
Breadth history (34 quarters)
Past Lit Events & Aftermath 6 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q1 | Top 11% | -21.0% | -33.1% |
| 2023Q2 | Top 8% | -27.5% | -17.7% |
| 2023Q1 | Top 14% | -24.4% | -44.0% |
| 2022Q2 | Top 15% | -9.2% | +24.7% |
| 2019Q2 | Top 12% | -39.0% | -39.9% |
| 2018Q2 | Top 16% | -38.3% | -40.9% |
Options Sentiment
Put holders
2
QoQ: +1
Call holders
3
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-1.98
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
-45.5%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)